Skin acts as the first line of defense against pathogens and other harmful material from outside the body. Yet this barrier also excludes some beneficial drugs that could treat skin diseases. Now, researchers have taken the first steps in developing a chemotherapy for melanoma that can be “painted” directly on the skin, rather than injected or taken orally.
They report their results in ACS Nano.
According to the Skin Cancer Foundation, melanoma is the deadliest form of cancer because of its tendency to spread, or metastasize, from the skin to other parts of the body. Common treatments include surgery, radiation therapy and intravenous chemotherapy, but these can cause pain or unpleasant side effects. If scientists could find a way to administer chemotherapy through the skin, they could target the treatment directly to the tumor site and possibly avoid side effects. Bingfang He, Ran Mo and colleagues wanted to develop a gel that patients themselves could apply to a skin tumor. But first they had to figure out how to get the therapy to penetrate deep within the skin.
For this purpose, the researchers assembled nanoparticles called “transfersomes,” which consist of a phospholipid bilayer and surfactants that encapsulate drugs or other molecules — in this case, the chemotherapy drug paclitaxel. The surfactants made the particles more deformable so that they could better infiltrate the skin; these compounds also affected the lipid matrix of the skin to help the particles more easily pass. The researchers added a peptide to the surface of the transfersome to further help the particle penetrate the skin, as well as enter tumor cells. To increase the time that the transfersomes persisted on skin, the researchers embedded the nanoparticles into a hydrogel. Then, they painted the gel on tumors of melanoma-bearing mice once a day, in combination with intravenous administration of paclitaxel every other day. After 12 days, the tumors of these mice were about half the size of tumors in mice treated with intravenous paclitaxel alone, suggesting that the transfersome gel helped slow tumor growth.
The Latest on: Melanoma
via Google News
The Latest on: Melanoma
- Melanoma Research at University of Iowa on April 17, 2019 at 8:00 am
Melanoma is the deadliest form of skin cancer because it easily spreads to other vital organs and is hard to fight. Dr. Michael Henry from University of Iowa Hospitals explains the newest melanoma ... […]
- Melanoma Monday: The fight against skin cancer begins in your head – act now on April 17, 2019 at 4:41 am
A melanoma skin cancer campaign has been launched to raise awareness and promote the prevention, early detection and treatment of the commonest skin-related cause of death worldwide. Monday 6 May will ... […]
- It's Melanoma Awareness Month. Pledge to take better care of your skin. on April 16, 2019 at 2:37 pm
It's Melanoma Awareness Month. Pledge to take better care of your skin. The American Cancer Society says more than 96,000 new melanomas will be diagnosed in 2019, and 7,230 people will die from ... […]
- Acral Lentiginous Melanoma Market 2019 – 2025 Analysis Scrutinized in new research | Chiron Corporation, Prometheus Laboratories, on April 16, 2019 at 7:37 am
The report on the global Acral Lentiginous Melanoma market is comprehensively prepared with main focus on the competitive landscape, geographical growth, segmentation, and market dynamics, including ... […]
- New treatment available for non-melanoma skin cancer on April 16, 2019 at 5:22 am
PHOENIX (3TV/CBS 5) --More people have skin cancer than any other cancer and the numbers just keep rising. In fact, more than 3.5 million cases are diagnosed in the U.S. each year and experts say the ... […]
- Mechanism of resistance to BRAF inhibitors in melanoma identified on April 15, 2019 at 1:41 pm
Melanoma is one of the most aggressive types of skin cancer, but recent advances in targeted therapies have improved the prognosis for many patients. Unfortunately, for some patients these positive ... […]
- Researchers identify mechanism of resistance to BRAF inhibitors in melanoma on April 15, 2019 at 9:14 am
Melanoma is one of the most aggressive types of skin cancer, but recent advances in targeted therapies have improved the prognosis for many patients. Unfortunately, for some patients these ... […]
- ONS Chapter Addresses Prevention, Early Detection of Melanoma Through “Hairstylist Melanoma Challenge” on April 13, 2019 at 5:45 pm
The following article features coverage from the Oncology Nursing Society (ONS) 2019 Annual Congress. Click here to read more of Oncology Nurse Advisor‘s conference coverage. ANAHEIM, CA — Learning of ... […]
- Skin cancer cases on the rise and it's not just melanoma you need to keep an eye on on April 12, 2019 at 10:38 pm
SAN FRANCISCO (KGO) -- Skin cancer is the most common cancer on earth, and according to new research, it's not going anywhere any time soon. According to the American Cancer Society melanoma, one ... […]
via Bing News